Compare ARK Genomic Revolution ETF (ARKG) vs JD.Com Inc (JD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs JD.Com Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while JD.Com Inc trades at $28.82 (market cap $38.39B). The key difference: JD.Com Inc pays a 3.55% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, JD.Com Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | JD | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $36.17 |
52-Week Low | $23.09 | $25.19 |
Market Cap | — | $38.39B |
Enterprise Value | — | $24.55B |
Dividend Yield | — | 3.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
JD.com trades at $28.20, up 1.66% today, with a bullish technical signal from moving averages. The company reported revenue of $1.31 trillion in 2025, though net income fell to $19.63 billion, reducing the profit margin to 1.49%. Recent quarters show consistent earnings beats, and analyst sentiment is strongly positive with a consensus price target of $39.20. News highlights include a rally in Chinese tech stocks and ongoing legal investigations.
The outlook is supported by low valuation multiples and strong cash flow, but risks include regulatory scrutiny and margin pressure. Upside potential exists if earnings growth resumes, yet investor caution is warranted due to legal overhangs and competitive dynamics in e-commerce.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About JD.Com Inc
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →
